Oral Cavity Cancer Clinical Trial
— IDECABOfficial title:
Screening for Cancers in the Oral CAvity Targeting Tobacco Users in Somme, France
In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media). The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 2028 |
Est. primary completion date | December 2028 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 75 Years |
Eligibility | Inclusion Criteria: - Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme - lives in somme departement Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
France | Amiens University Hospital | Amiens | Picardie |
France | Amiens University Hospital | Amiens | Picardie |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire, Amiens | Association for the screening of diseases in Somme (Adema 80), Picardy - Regional health agency (ARS), Regional Council Picardie, Regional Observatory of Health and Social Issues in Picardie (OR2S), Somme Cancer Registry |
France,
Bailey EE, Marghoob AA, Orengo IF, Testa MA, White VR, Geller AC. Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in Houston, Texas. Arch Dermatol. 2011 Oct;147(10):1159-65. doi: 10.1001/archdermatol.2011.184. — View Citation
Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008 Jun;44(6):538-44. doi: 10.1016/j.oraloncology.2007.08.011. Epub 2007 Nov 8. Erratum In: Oral Oncol. 2008 Jun;44(6):615. — View Citation
http://www.cepidc.vesinet.inserm.fr/
Hubert A, Lapôtre B, Raverdy N, Ganry O. Incidence et mortalité 2002-2004 Evolution de 1982 à 2004. Registre du Cancer de la Somme. Juin 2009. 138 p.
Réseau Francim, service de biostatistique des hospices civils de Lyon. Survie des patients atteints de Cancer en France : étude des registres du réseau Francim, Paris 2007, springer, 406
Reyt E, Righini C. Les cancers du plancher buccal. La chirurgie mini-invasive. Société française de carcinologie cervico-faciale.EDK
Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, Vinoda J, Ramadas K. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ. 2009 Mar;87(3):200-6. doi: 10.2471/blt.08.053231. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Participation rate to the screening of the target patients. | Numbers of people who benefit from a screening exam by a physician of the Somme region in comparison, with the target population of the Somme region. This rate will be also calculated according the different of age and sex. | 03 months after the start of the incentive period | |
Secondary | The participation rate of the physicians. | Number of physicians who send back at least one clinical form compared to the numbers of physician of the Somme. | 03 months after the start of the incentive period | |
Secondary | The participation rate of the tobacco venders. | The number of tobacco venders who gave at least 01 " Flyer " in comparison to the numbers of tobacco venders of the Somme. | 15 days after the start of the incentive period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01695122 -
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Recruiting |
NCT05793151 -
Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Recruiting |
NCT05757817 -
Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae
|
N/A | |
Active, not recruiting |
NCT02586207 -
Pembrolizumab in Combination With CRT for LA-SCCHN
|
Phase 1 | |
Recruiting |
NCT04809324 -
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
|
N/A | |
Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
Terminated |
NCT03555721 -
CytID Analysis of Oral Lesions
|
||
Completed |
NCT01116843 -
Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment
|
Phase 1/Phase 2 | |
Recruiting |
NCT05375266 -
Immune Biomarker Study for Head and Neck Cancer
|
||
Active, not recruiting |
NCT03082534 -
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT03096808 -
Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 2 | |
Completed |
NCT00359645 -
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
|
Phase 3 | |
Completed |
NCT02412241 -
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
|
N/A | |
Terminated |
NCT00934739 -
A Study of High-Risk Oral Cavity Cancer
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06407570 -
Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment
|
||
Recruiting |
NCT05337631 -
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
|
||
Recruiting |
NCT05927220 -
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
|
||
Recruiting |
NCT05369234 -
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
|
Phase 3 | |
Completed |
NCT05056064 -
Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap Reconstruction
|
N/A |